|
Re: FDA meeting
|
4
|
Resverlogix Corp.
|
Aug 09, 2022 03:31PM
|
|
Re: Can't be long now..
|
4
|
Resverlogix Corp.
|
Apr 27, 2020 05:09AM
|
|
Re: More volume than usual this early in the trading day....
|
4
|
Resverlogix Corp.
|
Mar 07, 2016 06:12PM
|
|
Re: Important article published yesterday (January 4), RVX208 relevant
|
4
|
Resverlogix Corp.
|
Jan 06, 2019 07:21PM
|
|
Re: Buck twenty
|
4
|
Resverlogix Corp.
|
Feb 21, 2018 12:21PM
|
|
Re: NR on phase 1 Kidney Trial
|
4
|
Resverlogix Corp.
|
Jan 23, 2017 03:49PM
|
|
Re: I think everyone has expressed their opinions enough...
|
4
|
Resverlogix Corp.
|
Feb 01, 2019 11:50AM
|
|
Re: Still no trial.....wow
|
4
|
Resverlogix Corp.
|
Apr 30, 2021 07:09AM
|
|
Re: New article on BET Inhibitors in Cardiovascular Disease
|
4
|
Resverlogix Corp.
|
Jan 30, 2019 05:06PM
|
|
Re: CIBC hellbent on torpedoing RVX
|
4
|
Resverlogix Corp.
|
Jun 15, 2017 05:12PM
|
|
Re: Quote from a January 19, 2021 review
|
4
|
Resverlogix Corp.
|
Jan 21, 2021 03:40PM
|
|
Re: Todays presentation
|
4
|
Resverlogix Corp.
|
May 12, 2021 01:18PM
|
|
Re: Dr Sweeney
|
4
|
Resverlogix Corp.
|
Jun 21, 2016 08:49PM
|
|
Resverlogix Highlights Potential to Develop Apabetalone as a Therapeutic for HIV-1 Eradication Utilizing the “Shock and Kill” Approach
|
4
|
Resverlogix Corp.
|
Jun 07, 2018 07:57AM
|
|
Re: Share price, why we stay
|
4
|
Resverlogix Corp.
|
Nov 18, 2020 10:59AM
|
|
Re: We Need The Futility Analysis
|
4
|
Resverlogix Corp.
|
Feb 07, 2018 09:06AM
|
|
Re: Why have we not heard more about CURATE-AI?
|
4
|
Zenith Epigenetics
|
Mar 26, 2021 07:28AM
|
|
Re: No data, No communication,,no interest!!
|
4
|
Zenith Epigenetics
|
Dec 29, 2023 02:09PM
|
|
Re: Is this sleeping beauty
|
4
|
Resverlogix Corp.
|
Jul 16, 2020 12:41PM
|
|
Re: Eye on the End Game
|
4
|
Resverlogix Corp.
|
Jun 19, 2018 11:00AM
|
